Prednisone Recruiting Phase 1 Trials for Metastatic Castration Resistant Prostate Cancer / Prostatic Neoplasms Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02861573Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)